BIOMAT Database Logo BIOMAT Database Logo

The biotransformation of ciclazindol in man. 1979

A J Swaisland, and R A Franklin, and A C White

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

A J Swaisland, and R A Franklin, and A C White
The biotransformation of ethrane in man.
September 1971, Anesthesiology,
A J Swaisland, and R A Franklin, and A C White
Halothane biotransformation in man.
July 1971, Annals of the New York Academy of Sciences,
A J Swaisland, and R A Franklin, and A C White
Biotransformation of prazepam in man.
July 1971, Annals of the New York Academy of Sciences,
A J Swaisland, and R A Franklin, and A C White
Biotransformation of tetroxoprim in man.
November 1979, The Journal of antimicrobial chemotherapy,
A J Swaisland, and R A Franklin, and A C White
Biotransformation of fluroxene in man.
June 1974, Anesthesiology,
A J Swaisland, and R A Franklin, and A C White
Biotransformation of irbesartan in man.
May 1998, Drug metabolism and disposition: the biological fate of chemicals,
A J Swaisland, and R A Franklin, and A C White
Biotransformation of 4-dimethylaminophenol in man.
March 1981, Archives of toxicology,
A J Swaisland, and R A Franklin, and A C White
Differences in the biotransformation of halothane in man.
February 1970, Anesthesiology,
A J Swaisland, and R A Franklin, and A C White
Trifluoroethanol and halothane biotransformation in man.
November 1971, Anesthesiology,
A J Swaisland, and R A Franklin, and A C White
Cocaine: pharmacokinetics and biotransformation in man.
September 1989, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!